IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dose form products in Australia and internationally. It offers analytical method development, stability chambers, chemistry and microbiology quality control laboratory, and quality assurance services. The company also provides project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs, as well as pharmaceutical development services in various dosage forms. In addition, it offers medicinal cannabis products, as well as various contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.
Stock data | 2023 | Change |
---|---|---|
Price | $0.08127218053260368 | N/A |
Market Cap | $28.57M | N/A |
Shares Outstanding | 351.48M | 46.34% |
Employees | 0 | N/A |
Shareholder Equity | 24.14M | -10.55% |
Valuation | 2023 | Change |
---|---|---|
P/S Ratio | 6.08 | N/A |
P/B Ratio | 1.18 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | -0.2384 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $4.70M | N/A |
Earnings | -$5.76M | N/A |
Gross Margin | 0.6855 | N/A |
Operating Margin | -1.42 | N/A |
Net income margin | -1.23 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $19.16M | N/A |
Cash on Hand | $3.00M | N/A |
Debt to Equity | 0.1164 | 49.97% |
Current Ratio | $2.45 | -50.98% |